Intuitive Surgical: Forex & Regulatory Woes Continue to Hurt
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 9:06AM CDT
Intuitive Surgical has been facing several headwinds including Foreign exchange headwinds and delayed market acceptance.
ISRG: 651.45 (+6.28), IRMD: 21.34 (-0.14), MASI: 51.69 (unch), CRY: 11.85 (-0.15)
Zacks.com featured highlights: Cable ONE, Masimo, Globant S.A., Altisource Portfolio Solutions S.A. and CommVault Systems
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks.com featured highlights: Cable ONE, Masimo, Globant S.A., Altisource Portfolio Solutions S.A. and CommVault Systems
CABO: 502.54 (+4.92), MASI: 51.69 (unch), GLOB: 39.70 (-0.13), ASPS: 26.70 (-0.62), CVLT: 44.93 (-0.85)
Stryker (SYK) Hits 52-Week High on Positive FY16 View
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 9:14AM CDT
Share price of Stryker Corp (SYK) rallied to a new 52-week high of $116.99 on Jun 20.
MASI: 51.69 (unch), BAX: 44.94 (-0.07), CRY: 11.85 (-0.15), SYK: 116.62 (+0.16)
These 5 Liquid Stocks Have the Potential to Outperform
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:48AM CDT
A strategy that seeks to invest in shares of companies having favorable liquidity positions is poised to yield healthy returns irrespective of market conditions.
CABO: 502.54 (+4.92), MASI: 51.69 (unch), GLOB: 39.70 (-0.13), ASPS: 26.70 (-0.62), CVLT: 44.93 (-0.85)
Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:17AM CDT
On Jun 20, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
MASI: 51.69 (unch), TMO: 149.85 (+0.94), CRY: 11.85 (-0.15), MLAB: 121.46 (-0.65)
Global Patient Monitoring Devices Market Worth USD 33.9 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Abbott Labs, Omron Healthcare, Masimo Corp - Research and Markets
BusinessWire - Fri Jun 17, 2:40PM CDT
Research and Markets has announced the addition of the "Global Patient Monitoring Devices Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
ABT: 38.74 (+1.01), MASI: 51.69 (unch)
IRadimed (IRMD) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:18AM CDT
On Jun 17, Zacks Investment Research raised IRadimed Corp. (IRMD) to a Zacks Rank #1 (Strong Buy).
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), CRY: 11.85 (-0.15), MLAB: 121.46 (-0.65)
Accuray Wins 7 TomoTherapy Orders from NHS, Stock Up
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:15AM CDT
Accuray (ARAY) recently won seven TomoTherapy System orders from NHS Supply Chain in the U.K.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), ARAY: 5.13 (+0.05), CRY: 11.85 (-0.15)
Varian Medical Clinches TrueBeam System Order in Australia
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 6:47AM CDT
Varian Medical Systems Inc. (VAR) won order from Australia-based Icon Group to supply 10 additional TrueBeam medical linear accelerators.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), VAR: 83.08 (+0.84), CRY: 11.85 (-0.15)
Masimo O3 Regional Oximetry Device Gets FDA 510 (k) Nod
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:21AM CDT
Masimo Corporation (MASI) recently announced the receipt of FDA 510 (k) approval for the O3 regional oximetry device.
HYH: 32.77 (+0.57), IRMD: 21.34 (-0.14), MASI: 51.69 (unch), CRY: 11.85 (-0.15)
Exactech (EXAC) Scales a 52-Week High on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:58AM CDT
Share price of Exactech Inc (EXAC) reached a new 52-week high of $25.86 on Jun 14.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), EXAC: 26.12 (-0.63), CRY: 11.85 (-0.15)
Intuitive Surgical and InTouch Health Form Partnership
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:24AM CDT
Intuitive Surgical Inc. (ISRG) recently inked a strategic partnership with telehealth network and managed services provider, InTouch Health.
ISRG: 651.45 (+6.28), IRMD: 21.34 (-0.14), MASI: 51.69 (unch), CRY: 11.85 (-0.15)
Cantel Medical (CMN) Q3 Earnings & Sales Up, Shares Fall
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:23AM CDT
Cantel Medical Corp. (CMN) reported adjusted earnings of 44 cents per share, which surged 25.7% from the year-ago quarter.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), CRY: 11.85 (-0.15), CMN: 70.29 (-0.66)
CryoLife (CRY) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:05AM CDT
On Jun 11, Zacks Investment Research raised CryoLife Inc. (CRY) to a Zacks Rank #1 (Strong Buy).
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), CRY: 11.85 (-0.15), MLAB: 121.46 (-0.65)
DENTSPLY (XRAY) Scales a 52-Week High on Strong Q1 Results
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 6:02AM CDT
Shares of DENTSPLY International Inc. (XRAY) rallied to a new 52-week high of $64.59 on Jun 9.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), EXAC: 26.12 (-0.63), XRAY: 63.47 (+0.07)
TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive (Revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 3:37AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), TROV: 4.58 (unch), EXAC: 26.12 (-0.63)
Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), VAR: 83.08 (+0.84), CRY: 11.85 (-0.15)
Masimo Announces Full Market Release of Next Generation SpHb(R) Spot Check Pronto(R)
BusinessWire - Wed Jun 08, 7:06AM CDT
Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto(R) Pulse CO-Oximeter(R) with Next Generation SpHb(R) Spot Check technology. Next Generation Pronto features rainbow SET(TM) technology, for noninvasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI).
MASI: 51.69 (unch)
Masimo Has Returned 31.9% Since SmarTrend Recommendation (MASI)
Comtex SmarTrend(R) - Wed Jun 08, 1:02AM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 3 months, Masimo has returned 31.93% as of today's recent price of $51.57.
MASI: 51.69 (unch)
TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:39AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations in the urine of patients with non-small cell lung cancer (NSCLC).
IRMD: 21.34 (-0.14), MASI: 51.69 (unch), TROV: 4.58 (unch), EXAC: 26.12 (-0.63)